-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or ...
Modular Medical ( (MODD)) just unveiled an announcement. On June 30, 2025, Modular Medical disclosed that its shares had traded below Nasdaq’s $1 minimum bid price for 30 consecutive business days, ...
-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA, CA / ACCESS Newswire / October 6, 2025 ...
Modular Medical Announces Successful Validation of Controller Line for Pivot Insulin Delivery System
Pivot Controller Line Validated: Manufacturing line has now been validated for human-use production in support of expected Q1 2026 market launch. Pivot will be First Two-Part Tubeless Patch Pump: ...
SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...
SAN DIEGO, CA / ACCESS Newswire / September 15, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a leader in innovative insulin delivery technology targeting the $3 ...
-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps Bosshard's appointment comes at a pivotal time, as ...
-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump Modular Medical's second-generation tubeless platform, its Pivot pump, builds on the Company's FDA-cleared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results